1. Home
  2. SUPX vs BHVN Comparison

SUPX vs BHVN Comparison

Compare SUPX & BHVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

SUPX

Super X AI Technology Limited Ordinary Shares

HOLD

Current Price

$11.35

Market Cap

1.7B

Sector

N/A

ML Signal

HOLD

Logo Biohaven Ltd.

BHVN

Biohaven Ltd.

HOLD

Current Price

$10.64

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SUPX
BHVN
Founded
2021
2013
Country
Singapore
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
1.6B
IPO Year
N/A
2022

Fundamental Metrics

Financial Performance
Metric
SUPX
BHVN
Price
$11.35
$10.64
Analyst Decision
Buy
Analyst Count
0
14
Target Price
N/A
$27.69
AVG Volume (30 Days)
253.4K
1.9M
Earning Date
01-01-0001
06-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
26.08
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$9.02
$7.48
52 Week High
$76.00
$31.80

Technical Indicators

Market Signals
Indicator
SUPX
BHVN
Relative Strength Index (RSI) 36.97 41.05
Support Level $9.98 $8.40
Resistance Level $19.09 $11.92
Average True Range (ATR) 1.18 0.64
MACD -0.26 -0.10
Stochastic Oscillator 18.24 25.79

Price Performance

Historical Comparison
SUPX
BHVN

About SUPX Super X AI Technology Limited Ordinary Shares

Super X AI Technology Ltd is an AI infrastructure solutions provider. Through its subsidiaries, SuperX offers a comprehensive portfolio of proprietary hardware, advanced software, and end-to-end services for AI data centers. The Company's services include advanced solution design and planning, cost-effective infrastructure product integration, and end-to-end operations and maintenance. Its core products include high-performance AI servers, High-Voltage Direct Current (HVDC) solutions, high-density liquid cooling solutions, as well as AI cloud and AI agents. The Company serves institutional clients globally, including enterprises, research institutions, and cloud and edge computing deployments.

About BHVN Biohaven Ltd.

Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others.

Share on Social Networks: